Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
暂无分享,去创建一个
J. Bloom | A. Hurt | T. Bedford | Juhye M. Lee | R. Eguia | Seth J. Zost | S. Choudhary | P. Wilson | T. Stevens-Ayers | M. Boeckh | S. Lakdawala | S. Hensley | Rachel T. Eguia
[1] C. Stuart-harris,et al. A NEUROTROPIC STRAIN OF HUMAN INFLUENZA VIRUS , 1939 .
[2] A. S. Beare,et al. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses , 1972, Epidemiology and Infection.
[3] R. Couch. Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus. , 1975, Developments in biological standardization.
[4] Couch Rb. Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus. , 1975 .
[5] G. Air,et al. Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies. , 1979, Virology.
[6] R. Webster,et al. Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule , 1979, Nature.
[7] R. Webster,et al. Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. , 1980, Virology.
[8] R. Webster,et al. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies , 1981, Nature.
[9] I. Wilson,et al. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation , 1981, Nature.
[10] T. Hoskins,et al. Christ's Hospital 1978–79: An account of two outbreaks of influenza A H1N1 , 1982 .
[11] M. Lubeck,et al. Conformational changes at topologically distinct antigenic sites on the influenza A/PR/8/34 virus HA molecule are induced by the binding of monoclonal antibodies. , 1982, Virology.
[12] J. Yewdell,et al. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) , 1982, Cell.
[13] R B Couch,et al. Immunity to influenza in man. , 1983, Annual review of microbiology.
[14] J. Yewdell,et al. Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies , 1986, Journal of virology.
[15] B. Murphy,et al. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum , 1987, Journal of clinical microbiology.
[16] Tokiko Watanabe,et al. Generation of influenza A viruses entirely from cloned cDNAs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Webster,et al. A DNA transfection system for generation of influenza A virus from eight plasmids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Lapedes,et al. Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.
[19] Arthur Chun-Chieh Shih,et al. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution , 2007, Proceedings of the National Academy of Sciences.
[20] L. Jost. Partitioning diversity into independent alpha and beta components. , 2007, Ecology.
[21] James E. Crowe,et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors , 2008, Nature.
[22] J. D. Capra,et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen , 2009, Nature Protocols.
[23] Rahul Raman,et al. Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift , 2009, Science.
[24] G. Whittaker,et al. Modifications to the Hemagglutinin Cleavage Site Control the Virulence of a Neurotropic H1N1 Influenza Virus , 2010, Journal of Virology.
[25] David Baltimore,et al. Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance , 2010, Science.
[26] G. Air,et al. Immunodominance of Antigenic Site B over Site A of Hemagglutinin of Recent H3N2 Influenza Viruses , 2012, PloS one.
[27] J. Plotkin,et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses , 2013, The Journal of experimental medicine.
[28] D. Burke,et al. Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution , 2013, Science.
[29] J. Bloom,et al. A Mutant Influenza Virus That Uses an N1 Neuraminidase as the Receptor-Binding Protein , 2013, Journal of Virology.
[30] S. Nelson,et al. High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution , 2014, Scientific Reports.
[31] C. A. Russell,et al. Antibody landscapes after influenza virus infection or vaccination , 2014, Science.
[32] J. Bloom,et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season , 2014, Proceedings of the National Academy of Sciences.
[33] Y. Iba,et al. Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus , 2014, Nature Communications.
[34] Trevor Bedford,et al. Integrating influenza antigenic dynamics with molecular evolution , 2013, eLife.
[35] An Experimentally Determined Evolutionary Model Dramatically Improves Phylogenetic Fit , 2014, Molecular biology and evolution.
[36] M. Lässig,et al. A predictive fitness model for influenza , 2014, Nature.
[37] S. Hensley,et al. Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. , 2015, Cell reports.
[38] Patrick C. Wilson,et al. Immune history profoundly affects broadly protective B cell responses to influenza , 2015, Science Translational Medicine.
[39] Trevor Bedford,et al. nextflu: real-time tracking of seasonal influenza virus evolution in humans , 2015, Bioinform..
[40] D. Cummings,et al. Estimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data , 2015, PLoS biology.
[41] Min Huang,et al. High Preexisting Serological Antibody Levels Correlate with Diversification of the Influenza Vaccine Response , 2015, Journal of Virology.
[42] R. Daniels,et al. Focused antibody response to influenza linked to antigenic drift. , 2015, The Journal of clinical investigation.
[43] J. Wrammert,et al. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. , 2015, The Journal of clinical investigation.
[44] Brantley R. Herrin,et al. Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity , 2015, eLife.
[45] Jesse D. Bloom,et al. Software for the analysis and visualization of deep mutational scanning data , 2015, bioRxiv.
[46] Baoshan Zhang,et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination , 2016, Nature Medicine.
[47] James O. Lloyd-Smith,et al. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting , 2016, Science.
[48] Michael B. Doud,et al. Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin , 2016, Viruses.
[49] Trevor Bedford,et al. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses , 2015, Proceedings of the National Academy of Sciences.
[50] Hongmei Yang,et al. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine‐mediated immune protection , 2016, Immunology.
[51] D. Burke,et al. Selection of antigenically advanced variants of seasonal influenza viruses , 2016, Nature Microbiology.
[52] Judith M. Fonville,et al. Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection , 2015, The Journal of infectious diseases.
[53] Caitlin E. Mullarkey,et al. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus , 2016, Proceedings of the National Academy of Sciences.
[54] G. Lal,et al. Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection , 2017, PLoS pathogens.
[55] S. Hensley,et al. Immune history and influenza virus susceptibility. , 2017, Current opinion in virology.
[56] S. Kent,et al. Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults , 2017, The Journal of infectious diseases.
[57] J. Tregoning,et al. Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre , 2017, Front. Microbiol..
[58] J. Bloom,et al. Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody. , 2017, Cell host & microbe.
[59] Seth J. Zost,et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains , 2017, Proceedings of the National Academy of Sciences.
[60] Michael B. Doud,et al. Complete mapping of viral escape from neutralizing antibodies , 2016, bioRxiv.
[61] I. Wilson,et al. A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus. , 2017, Journal of molecular biology.
[62] Matthew Angel,et al. Defining B Cell Immunodominance to Viruses , 2017, Nature Immunology.
[63] Michael B. Doud,et al. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin , 2018, Nature Communications.
[64] P. Wilson,et al. Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance , 2018, Journal of Virology.
[65] Nicole M. Bouvier,et al. Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance , 2018, The Journal of clinical investigation.
[66] Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo , 2018, Journal of Virology.
[67] V. Simon,et al. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice , 2018, Journal of Virology.
[68] T. Bedford,et al. Seasonal influenza circulation patterns and projections for Feb 2018 to Feb 2019 , 2018, bioRxiv.
[69] Trevor Bedford,et al. Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants , 2018, Proceedings of the National Academy of Sciences.
[70] Trevor Bedford,et al. Nextstrain: real-time tracking of pathogen evolution , 2017, bioRxiv.
[71] R. Lerner,et al. A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site , 2018, Nature Communications.
[72] Alexander S. Rose,et al. NGLview–interactive molecular graphics for Jupyter notebooks , 2018, Bioinform..
[73] F. Krammer. The human antibody response to influenza A virus infection and vaccination , 2019, Nature Reviews Immunology.
[74] Henry A. Utset,et al. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. , 2019, Cell host & microbe.
[75] J. Bloom,et al. Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans , 2019, bioRxiv.
[76] J. Peiris,et al. Age-specific differences in the dynamics of protective immunity to influenza , 2018, Nature Communications.
[77] A. Monto,et al. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season. , 2019, The Journal of infectious diseases.
[78] J. Yewdell,et al. Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies , 2018, bioRxiv.
[79] George Georgiou,et al. Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations. , 2019, Cell host & microbe.
[80] J. Bloom,et al. Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin , 2019, bioRxiv.
[81] Ha T. Nguyen,et al. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018 , 2019, Scientific Reports.
[82] J. Bloom,et al. An Antigenic Atlas of HIV‐1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes , 2019, Immunity.